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Objective: To evaluate the preoperative radiotherapy and its role in anastomotic leakage.
Methods: A total of 327 patients who had an anterior resection (AR) in elective surgery
for a rectal carcinoma were selected and operated in our clinic of surgery during the
period from 2003 to 2015. Among them, 135 patients had a low anterior resection (LAR)
and the other 192 had an AR. This is a retrospective study. Chi-squared test was used to
evaluate statistical differences and the P < 0.05 was considered statistically signiﬁcant.
Results: A total of 126 patients had radiotherapy before surgery, and 50 of them had a
LAR. In the other 201 patients, surgery was the ﬁrst treatment modality, and 83 of them
had a LAR. We had an overall anastomotic leakage of 7.95% or 26% patients. Anasto-
motic leakage was found in 14 patients with LAR, 9 of which had radiotherapy before
surgery. From the 12 patients with AR who had an anastomotic leakage, 6 of them had
radiotherapy before surgery.
Conclusions: Radiotherapy may affect anastomotic healing and increase the risk of
leakage. This risk is higher in low anterior anastomoses where a protective stoma may be
considered. A better evaluation and support for patients with preoperative radiotherapy is
needed in order to diminish the concomitant risk factors as much as possible.1. Introduction
Anastomotic leakage is the main concern following the surgery
for rectal cancer. After dealing with the total mesorectum excision,
the surgeon must be aware of this life-threating early complication
which is often asymptomatic and associated with an increased
morbidity, mortality and local recurrence[1,2]. Numerous studies have
considered a lot of factors inﬂuencing negatively in anastomotic
healing, which increases the rate of leakage in colorectal
anastomosis[3,4]. Some of the most discussed factors are the level
and stage of tumor, the distance of tumor from anus, impaired
wound healing by different origins (immunosuppression, diabetes,
anemia, etc.), bowel preparation, male gender, etc[3,4]. Different
studies show that there is an increased risk in low anterior
resections (LAR) and coloanal anastomoses ranging from almost
1% to over 22%[5,6].
Preoperative radiotherapy and chemotherapy are accused to
increase the leakage rate as well. Current consensus of NationalComprehensive Cancer Network is that all rectal carcinomas
staged as IIB, III or IV according to TNM stage (classiﬁcation of
malignant tumor, according to Union for International Cancer
Control) should be treated by a multimodal approach. In these
cases, radiotherapy and chemotherapy should precede surgery, as
a downstage is achieved resulting in a better surgical approach[7–
9]. Some authors ﬁnd that radiotherapy does not improve the
overall survival rate after rectal cancer resection and may
constitute a signiﬁcant overtreatment for many patients[7].
The main concern to discuss is the increased anastomotic
leakage in patients who were treated with radiotherapy before
surgery[10]. There aremany controversial reports on this issue.May
be because of the multiple associated factors, sometimes they are
difﬁcult to determine. It is difﬁcult to conclude that radiotherapy is
an independent risk factor for anastomotic leakage after anterior
resection (AR) or other concomitant factors may inﬂuence.
Many studies show the role of radiotherapy in increasing early
postoperative complications, where anastomotic leakage is the
main concern[11,12]. Others have not shown such relation[13,14].
The new era of radiotherapy, where the linear accelerator
(LINAC) is replacing conventional cobalt therapy, is giving a
better result. The overall toxicity and the regional tissue collat-
eral effects are reduced. This leads to a more suitable surgical
approach after radiotherapy, probably with lower risk for anas-
tomotic leakage.
It should be always aware, because this complication may
present its clinical signs only later after surgery, even in patientsaccess article under the CC BY-NC-
Table 1
Demographic data of patients with and without preoperative chemo-radio
therapy (CRT).
Patients data CRT
(n = 126)
No CRT
(n = 201)
Sex Male 67 20.5% 104 32.0%
Female 59 18.0% 97 29.5%
Mean age (years) 58.9 58.7
Average ASA score 2.6 2.4
Rectal cancer
TNM stage
Stage I (n = 54) 0 0.0% 54 16.5%
Stage II (n = 92) 9 2.8% 83 25.4%
Stage III (n = 116) 64 19.6% 52 15.9%
Stage IV (n = 65) 53 16.1% 12 3.7%
Surgical
procedure
AR 76 118
LAR 50 83
ASA: American Society of Anesthesiologists physical classiﬁcation
system; TNM: Classiﬁcation of malignant tumor, according to Union for
International Cancer Control.
Table 2
Anastomotic leakage in the three groups.
Group Operation Patients Anastomotic leakage
Group 1 (n = 201) AR 118 6
LAR 83 5
Group 2 (n = 84) AR 51 5
LAR 33 7
Group 3 (n = 42) AR 25 1
LAR 17 2
Table 3
Group comparison for anastomose leakage.
Comparison between groups Chi-squared value P
Group 2 vs. Group 1 6.202 0.012761
Group 3 vs. Group 1 0.178 0.673098
Group 2 vs. Group 1 AR 1.303 0.253666
LAR 5.873 0.015375
Group 3 vs. Group 1 AR 0.052 0.819619
LAR 0.714 0.398119
P < 0.05 was considered statistically signiﬁcant.
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indicating an emergent response to treat pelvic sepsis through a
defunctioning stoma and extensive drainage. Sometimes the
symptoms may be minimal or absent and the evidence may
present much later only in contrast imaging, showing signs of a
perianastomotic or cavity abscess[15].
The aim of this study was to evaluate the role of preoperative
radiotherapy in increasing the risk of anastomotic leakage.
2. Materials and methods
A total of 327 patients who had an AR in elective surgery for
a rectal carcinoma were selected and 126 of them had a course of
radiotherapy followed by the surgery within 1 week. All patients
aged from 40 to 65 years were selected with normal blood count
preoperatively and total mesorectal excision to minimize the
inﬂuence of other risk factors to this study. All the patients
having an elective AR with curative intention for preoperative
conﬁrmed rectal adenocarcinoma were operated in the third
Clinic of Surgery at Mother Teresa Hospital from January 2003
to December 2015. Patients who had a palliative surgery,
intraperitoneal dissemination and other organ metastases were
excluded. Remnant and recurrent rectal cancer were excluded as
well.
All the operated patients had a careful preoperative exami-
nation starting with patients' history (history of previous tumors,
neoadjuvant therapy and surgery), blood tests, tumor markers,
etc. Full colonoscopy was performed for every patient followed
by biopsy samples to locate the tumor and perform histopatho-
logical examination. Preoperative staging was based on radio-
logical data collected from abdominal CT with oral and venous
contrast. Other examinations were used to clarify tumor invasion
or metastases, as trans-rectal ultrasound, abdominal ultrasound,
chest X-rays or CT, etc.
Patients who had postoperative clinical signs of anastomotic
leakage, fever, purulent content or stools from drainage,
abdominal distension and compromised intestinal transit, had an
emergent abdominal ultrasound and blood tests followed by
abdominal CT. Patients with conﬁrmed signs of anastomotic
leakage were followed up with conservative therapy (liquids,
antibiotics, parenteral feeding) during a short period in which the
necessity of a decompressive stoma was evaluated.
Out of the 126 patients who had radiotherapy before sur-
gery, 83 were treated with cobalt therapy and the other 43
patients were treated with intensity modulated radiation therapy
(IMRT) through LINAC. The operated patients were divided
into three groups depending on the ﬁrst treatment modality
and the control group was the one with no preoperative
radiotherapy.
Statistical analysis was performed using Chi-square test to
compare the risk of anastomotic leakage among the groups.
P < 0.05 was considered statistically signiﬁcant.
The study protocol was performed according to the Helsinki
declaration and approved by Komiteti i Etikes Mjeksore (Medical
Ethics Commettee which approved the investigations). Informed
written consent was obtained from Medical Ethics Committee.
3. Results
A total of 327 patients who had an AR in elective surgery for
a rectal carcinoma were selected, in which 133 had a LAR and
the other 194 had an AR. One hundred and twenty-six patientshad radiotherapy before surgery and 50 of them had a LAR. In
the other 201 patients, surgery was the ﬁrst treatment modality,
83 of which had a LAR. We had an overall anastomotic leakage
in 7.95% or 26 patients. The anastomotic leakage was found in
14 patients with LAR, 9 of which had radiotherapy before sur-
gery. From the 12 patients with AR who had an anastomotic
leakage, 6 had radiotherapy before surgery. The demographic
data were shown in Table 1.The nine patients of stage II who had CRT before surgery were
considered IIB preparatory. The reason why some of the patients
of stage IV did not have CRT before surgery was preoperative
mistaken downstage or leakage of consent by their side.
All the 327 patients were divided into three groups (Group 1:
no radiotherapy; Group 2: cobalt therapy; Group 3: LINAC)
depending on the use of preoperative radiotherapy. Also for each
group, the number of patients were shown with anastomotic
leakage depending on the surgical procedure they had and the
data were shown in Table 2.Groups 2 and 3 were compared with the ﬁrst group for
anastomotic leakage and the data were given in Table 3.
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patients treated with preoperative cobalt radiotherapy (Group 2
vs. Group 1), especially for those who had a LAR. The patients
treated with IMRT through LINAC did not have a signiﬁcant
difference as compared with the control group.
4. Discussion
The major concern of a surgeon in elective surgery for rectal
carcinoma is the anastomotic healing following LAR. The
consequences of its failure are associated with serious morbidity
and mortality and may require an urgent surgical procedure.
There are many factors that inﬂuence in this complication. Some
depend on surgery and some did not. Even a meticulous pro-
cedure with no vascularity impairment and tension-free anasto-
motic construction may not be sufﬁcient. Preoperative factors
related to or not to the patient may affect healing biology. There
is a large list of these factors like low blood protein, leucopenia,
anemia and other patient conditions that affects the healing
process. Anastomotic leakage itself is generally diagnosed at the
late stage after surgery and often is asymptomatic[5,15]. This leads
to an increased risk for local infection and sepsis that often
require a permanent stoma as the ultimate solution[16].
Deciding if a protective stoma is necessary or not requires a
very accurate evaluation of every known risk factor, as well as
the psychological problems of patients, which is associated to
the stoma and their management. It is important to inform every
patient undergoing this kind of surgery for the risk of compli-
cations despite the location and stage of tumor. Every patient has
the potential possibility to develop a complication with all the
consequences[11].
Physiopathology of this condition is clear. Early ﬁndings
following radiotherapy show mucosal hyperemia and acute tissue
edema. In the later stage, obliterating endarteritis and ﬁbrosis
impair rectal compliance and tissue oxygenation[17]. All these
alterations affect anastomotic healing. The aim of this study was
to evaluate radiotherapy as a risk factor for the anastomotic
leakage. It is important to decide which cases we should
perform the defunctioning stoma to avoid an urgent operation.
Previous studies have shown that the risk for anastomotic
leakage is reduced by the use of defunctioning stoma[18,19].
Others do not embrace this theory. Calculating complications
related to stoma itself and the necessity of another operation[20],
the surgeon should chose these cases with prudence.
In this study, the authors tried to exclude patients with other
known risk factors to have the possibility of a more accurate
evaluation as much as they could. For this purpose, the authors
grouped and compared patients depending on surgical procedure
they had (AR or LAR) to minimize the inﬂuence of this factor in
conclusions as well (Tables 2 and 3). In the previous studies[21],
no advantage of defunctioning stoma on anastomotic leakage
was found, hence it is not considered in this study.
Anastomotic leakage associated to neoadjuvant therapy var-
ies in different studies up to 10%–20%. Replacement of cobalt
therapy with IMRT through LINAC has diminished lateral ef-
fects of radiotherapy, like toxicity and extensive ﬁbrosis. This
promises better surgical approach and results. In this study, the
signiﬁcant difference was not found regarding to the anastomotic
leakage among the patients treated with preoperative radio-
therapy and those who did not had a preoperative radiotherapy
(Table 3). This means that preoperative IMRT may not be
considered for a defunctioning stoma, unless there areconcomitant risk factors. Otherwise, conventional radiotherapy
through cobalt will increase the risk of anastomotic leakage
(Table 3). Also, it is considered that radiotherapy through cobalt
predisposes to an extensive ﬁbrosis of the treated area, which for
sure is unpleasant to the operatory surgeon. Counting the
toxicity of the procedure itself as well, it might be considered the
defunctioning stoma after resecting the tumor, especially when
performing a LAR (Table 3).
Finally, it should be aware that a small number of patients
treated with IMRT make the further investigation more than
necessary. Also, several data may be missed as they were
collected retrospectively leading to lack of evidence for the
exclusion criteria mentioned above.
To draw the conclusion, patients undergoing an AR for rectal
carcinoma after radiotherapy should be considered for a
defunctioning stoma, if they have a LAR, radiotherapy through
cobalt, or any other concomitant risk factor. IMRT through
LINAC alone should not be considered as an important risk
factor for anastomotic leakage.Conﬂict of interest statement
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